CD44 and hepatocellular carcinoma: Additionally, overexpression of the CD133+ CD44+ population in HCC cells promotes stem/progenitor cell properties, including extensive proliferation, self-renewal, differentiation, and increased resistance to chemotherapeutic agents, via upregulation of ABC transporters (ABCB1, ABCC1, and ABCG2) [21].